This is a big problem — it factored into the Food and Drug Administration's (FDA) decision to reject an MDMA-assisted therapy for PTSD this summer. These shortcomings need to be overcome for ...

PsychedeliCare, a movement that includes health care professionals, academics and advocates, launched the psychedelic therapy ...

The FDA granted Breakthrough Therapy Status in 2017 and MAPS is continuing its phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD at 15 sites in the US, Canada, and Israel.

One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for ...

A UCLA Health analysis of MDMA-assisted therapy research suggests that the drug could improve outcomes of treatment of a wider range of trauma-related conditions experienced by military personnel ...

Lykos Therapeutics is currently working out ways to fund an additional Phase III study for its MDMA-assisted PTSD therapy ...

The 90-subject study found that after three MDMA-assisted therapy sessions, 67% of participants with PTSD no longer qualified for that diagnosis, while 88% experienced a significant reduction in ...

Mental health professionals have made great advancements in the therapeutic use of psychedelic drugs in recent years. Some substances — like psilocybin, found in magic mushrooms; LSD; and MDMA ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

12/10/24 (LAPost.com) — A new UCLA Health analysis suggests MDMA-assisted therapy could benefit military personnel dealing with trauma-related conditions beyond post-traumatic stress disorder by ...

MDMA-assisted therapy for post-traumatic stress disorder. This decision comes just months after advisors to the agency voted against evidence supporting MDMA therapy . The agency's decision was ...